| Literature DB >> 15817768 |
Shinya Fukumoto1, Yoh Tamaki, Hiroaki Shirafuji, Shinji Harakawa, Hiroshi Suzuki, Xuenan Xuan.
Abstract
This is a report of a vaccine trial directed against Babesia gibsoni infection in dogs with the use of the recombinant antigen P50. Dogs immunized with P50 showed partial protection manifested as a significantly low level of parasitemia. The results indicated that P50 is a primary vaccine candidate molecule against canine B. gibsoni infection.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15817768 PMCID: PMC1074387 DOI: 10.1128/CDLI.12.4.557-559.2005
Source DB: PubMed Journal: Clin Diagn Lab Immunol ISSN: 1071-412X